These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21104395)
1. Mammalian MST2 kinase and human Salvador activate and reduce estrogen receptor alpha in the absence of ligand. Park Y; Park J; Lee Y; Lim W; Oh BC; Shin C; Kim W; Lee Y J Mol Med (Berl); 2011 Feb; 89(2):181-91. PubMed ID: 21104395 [TBL] [Abstract][Full Text] [Related]
2. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. Callus BA; Verhagen AM; Vaux DL FEBS J; 2006 Sep; 273(18):4264-76. PubMed ID: 16930133 [TBL] [Abstract][Full Text] [Related]
3. MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer. Park J; Kim GH; Lee J; Phuong BTC; Kong B; Won JE; Won GW; Lee YH; Han HD; Lee Y Toxicol Appl Pharmacol; 2020 Dec; 408():115257. PubMed ID: 33007383 [TBL] [Abstract][Full Text] [Related]
4. Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells. Katayama H; Sen S Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334 [TBL] [Abstract][Full Text] [Related]
5. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells. Linher-Melville K; Zantinge S; Singh G Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967 [TBL] [Abstract][Full Text] [Related]
7. Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation. Won GW; Park SH; Park J; Lee Y; Lee YH Biochem Biophys Res Commun; 2019 Apr; 512(1):87-92. PubMed ID: 30867124 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation. Al-Dhaheri MH; Rowan BG Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199 [TBL] [Abstract][Full Text] [Related]
10. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development. Thaler S; Schmidt M; Schad A; Sleeman JP Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866 [TBL] [Abstract][Full Text] [Related]
11. LATS2 is a modulator of estrogen receptor alpha. Lit LC; Scott S; Zhang H; Stebbing J; Photiou A; Giamas G Anticancer Res; 2013 Jan; 33(1):53-63. PubMed ID: 23267128 [TBL] [Abstract][Full Text] [Related]
12. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator. Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501 [TBL] [Abstract][Full Text] [Related]
13. Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells. Magne Nde CB; Casas Gimeno G; Docanto M; Knower KC; Young MJ; Buehn J; Sayed E; Clyne CD J Mol Biol; 2018 May; 430(10):1531-1543. PubMed ID: 29555554 [TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway. Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647 [TBL] [Abstract][Full Text] [Related]
15. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell. Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188 [TBL] [Abstract][Full Text] [Related]
16. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy. Fukui F; Hayashi SI; Yamaguchi Y J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines. Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876 [TBL] [Abstract][Full Text] [Related]
18. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. Liu H; Qiu J; Li N; Chen T; Cao X J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377 [TBL] [Abstract][Full Text] [Related]
19. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1. Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474 [TBL] [Abstract][Full Text] [Related]